Patients tend to assume that a prescription comes from a physician. Increasingly, and entirely legitimately, it does not. Understanding who is prescribing, and under what authority, is one of the more useful things a patient can know about a telehealth service, and one of the least discussed.
As of 2026, the American Association of Nurse Practitioners counts 27 states plus the District of Columbia granting nurse practitioners full practice authority, alongside Guam and the Northern Mariana Islands. Its state map records 27 full-practice jurisdictions, 12 reduced-practice and 11 restricted-practice.
For physician associates the position is considerably earlier in its development. As of October 2026, ten states have removed the supervising physician requirement, with the American Academy of Physician Associates pursuing further legislation in 2027.
What the three practice categories actually mean
The terminology is opaque from the outside and it determines something concrete.
Full practice authority means a nurse practitioner can evaluate patients, diagnose, order and interpret tests and prescribe independently, under the authority of the state board of nursing. No physician involvement is required.
Reduced practice means at least one element of practice requires a collaborative agreement with a physician. The nurse practitioner still provides the care; a formal relationship with a physician must exist alongside it.
Restricted practice means career-long supervision, delegation or team management by a physician is required for at least one element of practice.
The clinically important point is that these categories describe regulatory structure, not competence or training. A nurse practitioner in a restricted-practice state has the same qualification as one in a full-practice state. What differs is the paperwork the state requires around them.
Why this matters more in telehealth than anywhere else
Care is delivered where the patient is located, which means the applicable scope-of-practice rules are those of the patient’s state, not the clinician’s.
A nurse practitioner may therefore be able to prescribe independently for a patient in one state and require a collaborative agreement for a patient in the next. For a service operating nationally, that produces a matrix of requirements that has to be managed clinician by clinician and state by state.
Telehealth practice is generally more straightforward in states granting full practice authority, where independent services can be established without navigating collaboration requirements or supervisory agreements. In reduced and restricted states, a compliant national service needs physician collaborators in place for each of them.
Which is where a patient’s practical interest lies. Not in whether a nurse practitioner is prescribing, but in whether the service has actually built the structure their state requires.
Federal rules add a second layer
Prescribing authority sits under both state and federal rules, and the federal position has been in flux.
Through 31 December 2026, federal telemedicine flexibilities generally allow DEA-registered practitioners to prescribe Schedule II through V medications without a prior in-person visit, subject to stricter state telehealth laws for nurse practitioners.
That matters less for the main weight management medications, which are not controlled substances, than for adjacent prescribing. But it illustrates the general shape of the problem: a patient’s access depends on a stack of state scope rules, state telehealth rules and federal rules, any one of which can be the binding constraint, and none of which are visible on a sign-up page.
The quality question, answered honestly
The evidence on nurse practitioner care quality in primary care and chronic disease management is broadly favourable, and nurse practitioners are now a central part of how American primary care is delivered. For a condition like obesity, managed through assessment, prescribing, monitoring and follow-up, this is squarely within established nurse practitioner practice.
So the useful framing is not whether a nurse practitioner should be prescribing. It is whether the service is structured properly, and whether the clinician is identifiable.
That second point is where real differences between providers appear. Some services name the clinician responsible for a patient’s care, with credentials and a verifiable licence. Others present a brand and never name anyone, leaving the patient unable to establish who assessed them or under what authority.
How this works in practice
A service built around genuine clinical practice has to solve the state-by-state problem deliberately, because there is no shortcut. Clinician coverage has to be maintained per state, collaborative arrangements have to exist where required, and patients have to be matched to a clinician authorised for their location.
The TrimRx weight loss program works on that basis, pairing each patient with a licensed clinician authorised in the state where that patient is located, with dispensing through named pharmacy partners. The structural feature that matters to a patient is identifiability: a named, licensed clinician whose authority can be established, rather than an anonymous prescribing process.
It is the same test that separates a verifiable service from an unverifiable one anywhere else in this market. If you cannot find out who prescribed, you cannot find out anything else either.
What a patient can check
Three questions cover most of it.
Who is the clinician responsible for my care, and what is their credential? A service should answer by name.
Is that clinician licensed in my state? State licensing boards publish searchable registers, and verification takes a few minutes.
If this is a nurse practitioner or physician associate in a state requiring collaboration or supervision, is that arrangement in place? A properly structured service will have a straightforward answer, because they had to build it.
Where this is heading
The direction of travel is toward broader independent authority. Nurse practitioner full practice authority has expanded steadily, and physician associate legislation is following roughly a decade behind with active bills for 2027.
Telehealth is accelerating that, because a national service operating across a patchwork of state rules creates obvious pressure for harmonisation. The states that have moved to full practice authority are also the easiest to serve, which is itself an argument legislators are hearing.
For patients the practical conclusion is unchanged either way. The qualification of the prescriber is not the thing to worry about. Whether the prescriber can be named and verified is.
